{"id":"W4405039376","doi":"10.1182/blood-2024-211410","title":"Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Astellas Pharma; Incyte; Mallinckrodt Pharmaceuticals; Jazz Pharmaceuticals; Springworks Therapeutics; Regeneron Pharmaceuticals; Swedish Orphan Biovitrum; Therakos; Alexion Pharmaceuticals; Gilead Sciences; Les Laboratories Pierre Fabre; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Multiple myeloma; Refractory (planetary science); Lenalidomide; Medicine; Daratumumab; Dynamics (music); Cancer research; Hematologic Neoplasms; Internal medicine; Oncology; Biology; Cancer; Psychology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048511,0.0001493491,0.0004700654,0.0002466154,0.0001021268,0.0003959974,0.0001590465,0.000206308,0.0009966742],"category_scores_gemma":[0.001308437,0.00005767992,0.0003755519,0.0002015012,0.0002511439,0.0003472993,0.0002168784,0.0003072752,0.0001155285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001885102,"about_ca_system_score_gemma":0.0002225247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000124193,"about_ca_topic_score_gemma":0.0002641655,"domain_scores_codex":[0.9996768,0.0001085923,0.00003739946,0.00006350442,0.00005159024,0.00006206943],"domain_scores_gemma":[0.9990473,0.0002964124,0.0004129971,0.00005183532,0.00003841413,0.0001528916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1431312,0.003042152,0.5247098,0.0005224543,0.0007591576,0.000632467,0.0002100866,0.001201442,0.04563266,0.0002171848,0.00108161,0.2788597],"study_design_scores_gemma":[0.004123921,0.1135881,0.8627039,0.00007279597,0.0009900908,0.002287185,0.0001936793,0.001882039,0.01068752,0.0002622039,0.003180812,0.00002786971],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972915,0.001782559,0.0001564731,0.00005997353,0.00001354884,0.00001763412,0.00007752748,0.00001438378,0.0005863145],"genre_scores_gemma":[0.999445,0.0002033463,0.00008049243,0.00004491398,0.00002127815,0.000008560203,0.0001030155,0.000002283638,0.00009104449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001048511,"threshold_uncertainty_score":0.00554508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02366276717185334,"score_gpt":0.2792276280213069,"score_spread":0.2555648608494535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}